LianBio SEC filings LIANY
LianBio has 170 filings in SEC EDGAR's recent list, going back to Nov 12, 2020. Its latest annual report, Form 10-K, was filed on Mar 28, 2023 for the period ended Dec 31, 2022. The latest quarterly report (Form 10-Q) was filed on Nov 13, 2023, covering the quarter ended Sep 30, 2023. The most recent current report (Form 8-K) was filed on Feb 13, 2024 (exit or restructuring costs, listing notice, regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 15-12G | Deregistration | Mar 21, 2024 | — |
| EFFECT | Filing | Mar 12, 2024 | — |
| F-6 POS | Filing | Mar 12, 2024 | — |
| S-8 POS | Filing | Mar 12, 2024 | — |
| S-8 POS | Filing | Mar 12, 2024 | — |
| S-8 POS | Filing | Mar 12, 2024 | — |
| POS AM | Filing | Mar 12, 2024 | — |
| 25 | Filing | Mar 11, 2024 | — |
| 8-K |
Current report
Exit or restructuring costs, Listing notice, Regulation FD disclosure, Other events
|
Feb 13, 2024 | Feb 9, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Dec 26, 2023 | Dec 22, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 20, 2023 | Dec 19, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 19, 2023 | Dec 16, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 6, 2023 | Dec 6, 2023 |
| 8-K |
Current report
Other events
|
Dec 1, 2023 | Nov 30, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Regulation FD disclosure
|
Oct 30, 2023 | Oct 24, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| UPLOAD | Letter from the SEC | Jul 24, 2023 | — |
| CORRESP | Letter to the SEC | Jul 20, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 10, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2023 | Jun 21, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 1, 2023 | May 1, 2023 |
| EFFECT | Filing | Apr 27, 2023 | — |
| CORRESP | Letter to the SEC | Apr 26, 2023 | — |
| S-3/A | Filing | Apr 26, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 26, 2023 | Apr 26, 2023 |
| 8-K |
Current report
Other events
|
Apr 21, 2023 | Apr 21, 2023 |
| DEFA14A | Additional proxy material | Apr 19, 2023 | — |
| DEF 14A | Proxy statement | Apr 19, 2023 | Jun 21, 2023 |
| S-3/A | Filing | Mar 29, 2023 | — |
| CORRESP | Letter to the SEC | Mar 28, 2023 | — |
| S-8 | Employee stock plan registration | Mar 28, 2023 | — |
| 10-K | Annual report | Mar 28, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2023 | Mar 27, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 17, 2023 | Mar 14, 2023 |
| UPLOAD | Letter from the SEC | Dec 22, 2022 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 19, 2022 | Dec 16, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 13, 2022 | Dec 9, 2022 |
| CORRESP | Letter to the SEC | Dec 9, 2022 | — |
| S-3/A | Filing | Dec 9, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 28, 2022 | — |
| S-3 | Shelf registration | Nov 10, 2022 | — |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Other events
|
Oct 12, 2022 | Oct 12, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2022 | Jun 8, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 12, 2022 | May 12, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEFR14A | Filing | Apr 28, 2022 | — |
| DEFA14A | Additional proxy material | Apr 27, 2022 | — |
| DEF 14A | Proxy statement | Apr 27, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 8, 2022 | Apr 6, 2022 |
| S-8 | Employee stock plan registration | Mar 31, 2022 | — |
| 10-K | Annual report | Mar 31, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2022 | Mar 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 2, 2022 | Mar 2, 2022 |
| 10-Q/A | Amended quarterly report | Jan 10, 2022 | Sep 30, 2021 |
| 10-Q | Quarterly report | Dec 9, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Dec 9, 2021 | Dec 9, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 10, 2021 | Nov 4, 2021 |
| SEC STAFF LETTER | Filing | Nov 3, 2021 | — |
| S-8 | Employee stock plan registration | Nov 3, 2021 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 3, 2021 | Nov 3, 2021 |
| 424B4 | Prospectus | Nov 2, 2021 | — |
| EFFECT | Filing | Oct 29, 2021 | — |
| EFFECT | Filing | Oct 29, 2021 | — |
| S-1/A | Amended registration statement | Oct 29, 2021 | — |
| S-1/A | Amended registration statement | Oct 27, 2021 | — |
| CORRESP | Letter to the SEC | Oct 26, 2021 | — |
| F-6/A | Filing | Oct 26, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 26, 2021 | — |
| CORRESP | Letter to the SEC | Oct 25, 2021 | — |
| CORRESP | Letter to the SEC | Oct 25, 2021 | — |
| CERT | Filing | Oct 21, 2021 | — |
| 8-A12B | Filing | Oct 20, 2021 | — |
| S-1/A | Amended registration statement | Oct 20, 2021 | — |
| CORRESP | Letter to the SEC | Oct 8, 2021 | — |
| S-1/A | Amended registration statement | Oct 8, 2021 | — |
| F-6 | Filing | Oct 8, 2021 | — |
| CORRESP | Letter to the SEC | Oct 7, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 4, 2021 | — |
| S-1 | Registration statement | Oct 1, 2021 | — |
| DRSLTR | Filing | Sep 21, 2021 | — |
| DRS/A | Filing | Sep 21, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 14, 2021 | — |
| DRS/A | Filing | Sep 2, 2021 | — |
| DRSLTR | Filing | Sep 1, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 19, 2021 | — |
| DRSLTR | Filing | Aug 9, 2021 | — |
| DRS/A | Filing | Aug 9, 2021 | — |
| SEC STAFF LETTER | Filing | Aug 3, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 26, 2021 | — |
| DRS | Filing | Jun 28, 2021 | — |
| D | Filing | Apr 5, 2021 | — |
| D | Filing | Nov 12, 2020 | — |
Showing 102 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LIANY (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Princeton, NJ
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1831283
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.